Codes / ICD10CM / J12.2

J12.2 Parainfluenza virus pneumonia

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Parainfluenza virus pneumonia

Summary

Parainfluenza virus pneumonia is a viral infection of the lungs caused by parainfluenza viruses. It leads to inflammation of lung tissue, resulting in respiratory symptoms that can range from mild to severe. The condition is more common in children but can affect individuals of all ages, particularly those with weakened immune systems or underlying respiratory conditions.

Causes

Parainfluenza virus pneumonia is caused by parainfluenza viruses, which are transmitted through respiratory droplets, direct contact with infected individuals, or contact with contaminated surfaces. The virus infects the respiratory tract and can spread to the lungs, causing pneumonia.

Risk Factors

  • Close contact with infected individuals, especially in crowded settings like schools or daycare centers.
  • Weakened immune system due to underlying health conditions or immunosuppressive treatments.
  • Age: Children and older adults are at higher risk.
  • Pre-existing respiratory conditions, such as asthma or chronic obstructive pulmonary disease (COPD).

Symptoms

  • Fever and chills.
  • Cough, which may produce mucus.
  • Shortness of breath or difficulty breathing.
  • Wheezing or rapid breathing.
  • Chest pain or discomfort.
  • Fatigue and general malaise.
  • Sore throat or nasal congestion (may precede pneumonia).

Diagnosis

Diagnosis is based on clinical evaluation, including symptoms and patient history. Chest imaging (e.g., X-ray) may show signs of lung inflammation. Laboratory tests, such as viral cultures or polymerase chain reaction (PCR) tests, can confirm the presence of parainfluenza virus.

Treatment Options

Treatment focuses on managing symptoms and supporting respiratory function. This may include rest, hydration, and over-the-counter medications for fever or pain. Severe cases may require hospitalization for oxygen therapy or other supportive care. Antiviral medications are not typically used for parainfluenza virus pneumonia.

Prognosis and Follow-Up

Most individuals recover fully with appropriate care, though recovery time varies. Follow-up care may involve monitoring for complications, especially in high-risk groups. Severe cases can lead to respiratory distress or secondary infections, requiring additional medical attention.

Complications

  • Respiratory failure or acute respiratory distress syndrome (ARDS).
  • Secondary bacterial pneumonia.
  • Worsening of pre-existing chronic conditions, such as asthma or COPD.
  • Prolonged respiratory symptoms in immunocompromised individuals.

Lifestyle & Prevention

  • Practice good hand hygiene to reduce transmission.
  • Avoid close contact with infected individuals.
  • Ensure proper ventilation in shared spaces.
  • Stay up to date with vaccinations, as recommended by healthcare providers.
  • Avoid smoking and exposure to secondhand smoke, which can worsen respiratory symptoms.

When to Seek Professional Help

Seek medical attention if symptoms worsen, such as increased difficulty breathing, persistent high fever, or signs of dehydration. Immediate care is needed for severe respiratory distress, confusion, or bluish lips or skin, which may indicate low oxygen levels.

Tips for Medical Coders

When coding for parainfluenza virus pneumonia (J12.2), ensure documentation supports the diagnosis, including clinical findings, laboratory confirmation, or imaging results. Verify that the code aligns with the specific viral cause and any associated complications. Accurate coding requires clear documentation of the condition and its severity to reflect the clinical scenario appropriately.

Book a walkthrough

J12.2 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.